{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:19:43Z","timestamp":1792513183113,"version":"4.5.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,8]]},"DOI":"10.7759\/cureus.22029","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T17:45:41Z","timestamp":1644342341000},"source":"Crossref","is-referenced-by-count":2,"title":["Metaplastic Breast Carcinoma Presenting as a Mixed Solid and Cystic Lesion"],"prefix":"10.7759","author":[{"given":"Hassan","family":"Arekemase","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osmani","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usma","family":"Zafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohli","family":"Manpreet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Maghari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-79166-5","article-title":"The longitudinal risk of mortality between invasive ductal carcinoma and metaplastic breast carcinoma","volume":"10","author":"Wu SG","year":"2020","unstructured":"Wu SG, Yang SP, Zhang WW, Wang J, Lian CL, Chen YX, He ZY. The longitudinal risk of mortality between invasive ductal carcinoma and metaplastic breast carcinoma. Sci Rep. 2020, 10:22070. 10.1038\/s41598-020-79166-5","journal-title":"Sci Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/PAI.0000000000000873","article-title":"Best practice (efficient) immunohistologic panel for diagnosing metaplastic breast carcinoma","volume":"29","author":"Han M","year":"2021","unstructured":"Han M, Zhang H, Dabbs DJ. Best practice (efficient) immunohistologic panel for diagnosing metaplastic breast carcinoma. Appl Immunohistochem Mol Morphol. 2021, 29:265-9. 10.1097\/PAI.0000000000000873","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.clbc.2017.04.009","article-title":"Metaplastic carcinoma of the breast is more aggressive than triple-negative breast cancer: a\u00a0study from a single institution and review of\u00a0literature","volume":"17","author":"El Zein D","year":"2017","unstructured":"El Zein D, Hughes M, Kumar S, Peng X, Oyasiji T, Jabbour H, Khoury T. Metaplastic carcinoma of the breast is more aggressive than triple-negative breast cancer: a\u00a0study from a single institution and review of\u00a0literature. Clin Breast Cancer. 2017, 17:382-91. 10.1016\/j.clbc.2017.04.009","journal-title":"Clin Breast Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3233\/BD-170313","article-title":"Metaplastic carcinoma of the breast with mesenchymal differentiation (carcinosarcoma). A unique presentation of an aggressive malignancy and literature review","volume":"37","author":"Salemis NS","year":"2018","unstructured":"Salemis NS. Metaplastic carcinoma of the breast with mesenchymal differentiation (carcinosarcoma). A unique presentation of an aggressive malignancy and literature review. Breast Dis. 2018, 37:169-75. 10.3233\/BD-170313","journal-title":"Breast Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/tbj.13753","article-title":"Spindle cell metaplastic carcinoma of the breast","volume":"26","author":"Tekin L","year":"2020","unstructured":"Tekin L, Elibol FD, Bacaks\u0131zlar Sar\u0131 F, Nazl\u0131 O. Spindle cell metaplastic carcinoma of the breast. Breast J. 2020, 26:1421-2. 10.1111\/tbj.13753","journal-title":"Breast J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-017-1553-3","article-title":"Rare variant of metaplastic carcinoma of the breast: a case report and review of the\u00a0literature","volume":"12","author":"Alaoui M'hamdi H","year":"2018","unstructured":"Alaoui M'hamdi H, Abbad F, Rais H, Asmouki H, Soumani A, Khouchani M, Belbaraka R. Rare variant of metaplastic carcinoma of the breast: a case report and review of the\u00a0literature. J Med Case Rep. 2018, 12:43. 10.1186\/s13256-017-1553-3","journal-title":"J Med Case Rep"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s13053-020-00162-x","article-title":"Metaplastic carcinoma of the breast and BRCA1 germline mutation: a case report and review","volume":"19","author":"Yamashita M","year":"2021","unstructured":"Yamashita M, Kamei Y, Murakami A, et al.. Metaplastic carcinoma of the breast and BRCA1 germline mutation: a case report and review. Hered Cancer Clin Pract. 2021, 19:3. 10.1186\/s13053-020-00162-x","journal-title":"Hered Cancer Clin Pract"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s40792-021-01110-0","article-title":"A difficult-to-diagnose fibromatosis-like metaplastic carcinoma of the breast: a case report","volume":"7","author":"Takatsuka D","year":"2021","unstructured":"Takatsuka D, Ogura H, Asano Y, Nakamura A, Koizumi K, Shiiya N, Baba S. A difficult-to-diagnose fibromatosis-like metaplastic carcinoma of the breast: a case report. Surg Case Rep. 2021, 7:16. 10.1186\/s40792-021-01110-0","journal-title":"Surg Case Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2020-206468","article-title":"Clinicopathologic characteristics of HER2-positive metaplastic squamous cell carcinoma of the breast","volume":"75","author":"Lei T","year":"2022","unstructured":"Lei T, Pu T, Wei B, et al.. Clinicopathologic characteristics of HER2-positive metaplastic squamous cell carcinoma of the breast. J Clin Pathol. 2022, 75:18-23. 10.1136\/jclinpath-2020-206468","journal-title":"J Clin Pathol"},{"key":"ref10","article-title":"Metaplastic breast carcinoma. Rare form of mammary cancer","volume":"73","author":"Huvos AG","year":"1973","unstructured":"Huvos AG, Lucas JC Jr, Foote FW Jr. Metaplastic breast carcinoma. Rare form of mammary cancer. N Y State J Med. 1973, 73:1078-82.","journal-title":"N Y State J Med"},{"key":"ref11","unstructured":"Metaplastic carcinoma of the breast. (2011). Accessed. January 1, 2022: https:\/\/rarediseases.info.nih.gov\/diseases\/10804\/metaplastic-carcinoma-of-the-breast."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-020-01353-z","article-title":"A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations","volume":"22","author":"Reddy TP","year":"2020","unstructured":"Reddy TP, Rosato RR, Li X, Moulder S, Piwnica-Worms H, Chang JC. A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations. Breast Cancer Res. 2020, 22:121. 10.1186\/s13058-020-01353-z","journal-title":"Breast Cancer Res"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002341","article-title":"Metaplastic breast carcinoma versus triple-negative breast cancer: survival and response to treatment","volume":"94","author":"Aydiner A","year":"2015","unstructured":"Aydiner A, Sen F, Tambas M, et al.. Metaplastic breast carcinoma versus triple-negative breast cancer: survival and response to treatment. Medicine (Baltimore). 2015, 94:e2341. 10.1097\/MD.0000000000002341","journal-title":"Medicine (Baltimore)"},{"key":"ref14","unstructured":"Breast, metaplastic carcinoma. (2021). Accessed. January 1, 2022: https:\/\/www.pathologyoutlines.com\/topic\/breastmalignantmetaplastic.html."},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/1746-1596-9-139","article-title":"Metaplastic carcinoma of the breast: an immunohistochemical study","volume":"9","author":"Altaf FJ","year":"2014","unstructured":"Altaf FJ, Mokhtar GA, Emam E, Bokhary RY, Mahfouz NB, Al Amoudi S, Al-Gaithy ZK. Metaplastic carcinoma of the breast: an immunohistochemical study. Diagn Pathol. 2014, 9:139. 10.1186\/1746-1596-9-139","journal-title":"Diagn Pathol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-021-00302-z","article-title":"Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma","volume":"7","author":"Wong W","year":"2021","unstructured":"Wong W, Brogi E, Reis-Filho JS, et al.. Poor response to neoadjuvant chemotherapy in metaplastic breast carcinoma. NPJ Breast Cancer. 2021, 7:96. 10.1038\/s41523-021-00302-z","journal-title":"NPJ Breast Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101054","article-title":"Metaplastic breast cancer: treatment and prognosis by molecular subtype","volume":"14","author":"Hu J","year":"2021","unstructured":"Hu J, Zhang H, Dong F, Zhang X, Wang S, Ming J, Huang T. Metaplastic breast cancer: treatment and prognosis by molecular subtype. Transl Oncol. 2021, 14:101054. 10.1016\/j.tranon.2021.101054","journal-title":"Transl Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000138183.97366.fd","article-title":"p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma","volume":"28","author":"Koker MM","year":"2004","unstructured":"Koker MM, Kleer CG. p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma. Am J Surg Pathol. 2004, 28:1506-12. 10.1097\/01.pas.0000138183.97366.fd","journal-title":"Am J Surg Pathol"},{"key":"ref19","unstructured":"Metaplastic carcinoma of the breast. (2009). Accessed. December 26, 2021: http:\/\/surgpathcriteria.stanford.edu\/breast\/metacabr\/printable.html."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-11-129","article-title":"Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators","volume":"11","author":"Song Y","year":"2013","unstructured":"Song Y, Liu X, Zhang G, et al.. Unique clinicopathological features of metaplastic breast carcinoma compared with invasive ductal carcinoma and poor prognostic indicators. World J Surg Oncol. 2013, 11:129. 10.1186\/1477-7819-11-129","journal-title":"World J Surg Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/78783-metaplastic-breast-carcinoma-presenting-as-a-mixed-solid-and-cystic-lesion","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:44:21Z","timestamp":1707507861000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/78783-metaplastic-breast-carcinoma-presenting-as-a-mixed-solid-and-cystic-lesion"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,8]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.22029","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2,8]]}}}